Acute Coronary SyndromeSyndromeAngina, UnstableCoronary AngiographyMyocardial InfarctionCoronary VesselsCoronary Artery DiseasePlatelet Aggregation InhibitorsAngioplasty, Balloon, CoronaryCoronary DiseaseAcute DiseaseTiclopidineCoronary ThrombosisChest PainCoronary CirculationBiological MarkersHemorrhageElectrocardiographyRisk FactorsTreatment OutcomePlatelet Glycoprotein GPIIb-IIIa ComplexCoronary StenosisTroponin TCoronary Artery BypassProspective StudiesAngina PectorisPercutaneous Coronary InterventionMyocardial RevascularizationTroponin IRisk AssessmentMyocardial IschemiaPredictive Value of TestsTime FactorsPurinergic P2Y Receptor AntagonistsPrognosisAspirinPlaque, AtheroscleroticEnoxaparinCreatine Kinase, MB FormFollow-Up StudiesCoronary Care UnitsAnticoagulantsUltrasonography, InterventionalC-Reactive ProteinCoronary VasospasmHeptanoic AcidsTroponinStentsFibrinolytic AgentsAngina, StableHydroxymethylglutaryl-CoA Reductase InhibitorsHospitalizationThiophenesRecurrenceCardiovascular AgentsRupture, SpontaneousRetrospective StudiesRegistriesHirudinsAcetanilidesCoronary AneurysmPyrrolesHospital MortalityHeparinCoronary RestenosisThrombosisRandomized Controlled Trials as TopicKaplan-Meier EstimateSeverity of Illness IndexMultivariate AnalysisAngioscopyCoronary OcclusionTriageHirudin TherapyDrug Therapy, CombinationCardiac CatheterizationDouble-Blind MethodChi-Square DistributionCreatine KinaseThrombolytic TherapyProportional Hazards ModelsPravastatinPlatelet ActivationSensitivity and SpecificityMetabolic Syndrome XAlbaniaNatriuretic Peptide, BrainSecondary PreventionCohort StudiesIncidenceLogistic ModelsVascular CalcificationROC CurveCase-Control StudiesImmunoglobulin Fab FragmentsNo-Reflow PhenomenonEmergency Medical ServicesSurvival AnalysisAdenosinePlatelet Function Tests